Global News: Mother says pharmacy misfilled baby’s prescription
UC's Neil MacKinnon weighs in on medication mistakes and actions to correct them
A Canadian mother to a five-month-old said she had been to a Shoppers Drug Mart three times prior to fill her daughter's anti-reflux medication. But it was during the fourth visit that she said she was instead given an opioid. Luckily, the mother read the label before giving the child the medication.
Canada has taken steps to identify and control pharmacy errors, to include the Assurance and Improvement in Medication Safety program, which require medication incidents to be recorded into an independent third-party database.
In response to Global News' request for information, OCP revealed a summary of the program's outcome thus far. According to the latest data, over a 15-month period — February 2018 to May 1, 2019 — there were 4,426 "medication events" at the pharmacies in Ontario enrolled in AIMS.
UC's James L. Winkle College of Pharmacy Dean Neil MacKinnon, who researches medication errors, contributed to the article.
Feature photo credit: Unsplash
Related Stories
Recent advances may speed time to endometriosis diagnosis
March 16, 2026
The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.